SPCC2H8.04 Antibody

What is SPCC2H8.04 protein and why is it studied?

SPCC2H8.04 is a protein found in Schizosaccharomyces pombe (fission yeast), identified by UniProt accession number Q9Y7R1. This protein is studied in basic research to understand fundamental cellular processes in eukaryotic cells. S. pombe serves as an important model organism for studying cell cycle regulation, DNA damage responses, and other conserved cellular mechanisms . Research involving SPCC2H8.04 contributes to our understanding of protein function in lower eukaryotes that may have evolutionary conservation.

What are the key specifications of SPCC2H8.04 Antibody?

SPCC2H8.04 Antibody is a rabbit-derived polyclonal antibody specifically recognizing Schizosaccharomyces pombe (strain 972/ATCC 24843) SPCC2H8.04 protein. It is available in liquid form, with a storage buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4. The antibody has been purified using antigen affinity methods and is primarily tested for ELISA and Western Blot applications . The non-conjugated format allows researchers flexibility in experimental design.

How should SPCC2H8.04 Antibody be stored and handled?

For optimal preservation of antibody function, SPCC2H8.04 Antibody should be stored at -20°C or -80°C immediately upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can lead to protein denaturation and loss of antibody functionality. For experiments requiring frequent use, consider aliquoting the antibody into smaller volumes before freezing to minimize freeze-thaw cycles . When handling, maintain sterile conditions and use appropriate laboratory techniques to prevent contamination.

What is the recommended protocol for using SPCC2H8.04 Antibody in Western Blotting?

When performing Western Blotting with SPCC2H8.04 Antibody, follow these methodological steps:

• Sample preparation: Extract proteins from S. pombe using standard lysis protocols

• Protein separation: Run 10-30 μg of protein per lane on SDS-PAGE (10-12%)

• Transfer: Transfer proteins to PVDF or nitrocellulose membrane

• Blocking: Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Primary antibody: Dilute SPCC2H8.04 Antibody (start with 1:500-1:2000 range) in blocking buffer and incubate overnight at 4°C

• Washing: Wash 3-5 times with TBST

• Secondary antibody: Incubate with anti-rabbit HRP-conjugated secondary antibody

• Detection: Use chemiluminescence detection reagents

Optimization of antibody dilution is critical for obtaining specific signals with minimal background .

What controls should be included when validating SPCC2H8.04 Antibody?

Proper validation requires multiple controls to ensure specificity and reliability:

These controls collectively help distinguish specific signals from non-specific binding and establish optimal experimental conditions .

How can SPCC2H8.04 Antibody be used in ELISA applications?

For ELISA applications using SPCC2H8.04 Antibody:

• Coating: Coat microplate wells with recombinant SPCC2H8.04 protein (1-10 μg/ml) or cell lysate containing the target protein

• Blocking: Block with 1-5% BSA in PBS for 1-2 hours at room temperature

• Primary antibody: Add diluted SPCC2H8.04 Antibody (1:500-1:5000) and incubate for 2 hours at room temperature

• Washing: Wash wells 3-5 times with PBST

• Secondary antibody: Add HRP-conjugated anti-rabbit antibody and incubate for 1 hour

• Detection: Add substrate solution and measure optical density

For quantitative analysis, include a standard curve using purified SPCC2H8.04 protein at known concentrations .

What are common issues when using SPCC2H8.04 Antibody in Western blotting and how can they be resolved?

Here are methodological solutions for common Western blotting issues:

• No signal detected:

  • Verify protein expression in sample

  • Increase antibody concentration

  • Extend incubation time

  • Check secondary antibody compatibility

  • Use more sensitive detection method

• High background:

  • Increase blocking time or concentration

  • Decrease primary antibody concentration

  • Add 0.1-0.5% Tween-20 to antibody diluent

  • Increase washing steps duration and frequency

  • Use fresh blocking reagents

• Multiple bands:

  • Verify with known positive control

  • Test antibody specificity with antigen pre-adsorption

  • Optimize protein extraction protocol to reduce degradation

  • Increase gel percentage for better separation

• Weak signal:

  • Increase protein loading

  • Reduce washing stringency

  • Increase antibody concentration

  • Extend exposure time

  • Use signal enhancement systems

How can researchers determine the optimal dilution for SPCC2H8.04 Antibody?

To determine optimal dilution, perform a systematic titration experiment:

• Prepare identical membrane strips or ELISA wells with the same amount of target protein

• Test a range of antibody dilutions (e.g., 1:100, 1:500, 1:1000, 1:2000, 1:5000)

• Process all samples identically regarding incubation times, washing, and detection

• Evaluate signal-to-noise ratio for each dilution

• Select the dilution that provides strongest specific signal with minimal background

The optimal dilution may vary depending on protein abundance, sample type, and detection method. Include both positive and negative controls at each dilution to accurately assess specificity .

What strategies can improve signal specificity when working with SPCC2H8.04 Antibody?

To enhance signal specificity:

• Optimize blocking: Test different blocking agents (BSA, milk, commercial blockers) to determine which minimizes non-specific binding

• Adjust antibody incubation conditions: Compare room temperature vs. 4°C incubation and different durations

• Modify washing procedures: Increase wash duration or number of washes

• Add protein competitors: Add 0.1-0.2% BSA or 1-5% normal serum from the secondary antibody species to the primary antibody solution

• Use antigen pre-adsorption: Pre-incubate antibody with excess target antigen to verify signal specificity

• Optimize buffer components: Adjust salt concentration or add detergents to reduce non-specific interactions

Document all optimization steps methodically to establish reproducible protocols .

Can SPCC2H8.04 Antibody be used for immunoprecipitation or chromatin immunoprecipitation?

While SPCC2H8.04 Antibody is primarily validated for ELISA and Western blot applications, researchers may adapt it for immunoprecipitation (IP) or chromatin immunoprecipitation (ChIP) with appropriate optimization:

For IP:

• Couple the antibody to protein A/G beads or magnetic beads (typically 2-5 μg antibody per experiment)

• Prepare cell lysates under non-denaturing conditions

• Pre-clear lysates with beads alone to reduce non-specific binding

• Incubate pre-cleared lysates with antibody-coupled beads (4-16 hours at 4°C)

• Wash extensively to remove non-specifically bound proteins

• Elute and analyze precipitated complexes

For ChIP applications, additional optimization and validation would be required, including crosslinking efficiency testing and sonication optimization. In both cases, include appropriate controls such as IgG control and input samples .

How can SPCC2H8.04 Antibody be modified for fluorescence microscopy applications?

Though not explicitly validated for immunofluorescence, researchers may adapt SPCC2H8.04 Antibody for fluorescence microscopy using these approaches:

• Indirect immunofluorescence:

  • Fix and permeabilize S. pombe cells appropriately

  • Block with 1-5% BSA or normal serum

  • Incubate with SPCC2H8.04 Antibody (starting at 1:50-1:200 dilution)

  • Detect with fluorophore-conjugated anti-rabbit secondary antibody

• Direct labeling (for advanced applications):

  • Use commercial antibody labeling kits (Alexa Fluor, DyLight, etc.)

  • Follow manufacturer's protocol for direct conjugation

  • Optimize antibody:dye ratio to maintain binding activity

• Controls for immunofluorescence validation:

  • Cells lacking SPCC2H8.04 protein (negative control)

  • Secondary antibody only control

  • Peptide competition control

Detailed validation is essential as the antibody may recognize conformational epitopes differentially in fixed versus live cells .

What bioinformatic approaches can help interpret SPCC2H8.04 Antibody experimental results?

For comprehensive analysis of SPCC2H8.04 experimental data:

• Homology analysis: Compare S. pombe SPCC2H8.04 with homologs in other species using tools like BLAST, Clustal Omega, or HHpred to infer conserved functions

• Structural prediction: Use AlphaFold, I-TASSER, or Phyre2 to predict protein structure and potential functional domains

• Interaction network analysis:

  • Analyze IP-MS data through platforms like STRING, BioGRID, or Cytoscape

  • Identify interaction partners through Gene Ontology enrichment

• Quantitative image analysis for microscopy data:

  • Use ImageJ/Fiji with appropriate plugins for colocalization analysis

  • Apply deconvolution algorithms for improved resolution

  • Implement machine learning approaches for pattern recognition

• Integrated multi-omics analysis:

  • Correlate protein expression with transcriptomics data

  • Connect with phenotypic data from genetic screens

These computational approaches provide context for experimental observations and generate testable hypotheses .

What documentation practices ensure experimental reproducibility with SPCC2H8.04 Antibody?

Maintaining comprehensive documentation is critical for reproducible antibody-based experiments:

• Antibody information record:

  • Complete catalog information (manufacturer, catalog number, lot number)

  • Species, clonality, and immunogen details

  • Storage conditions and dilution used

  • Date of receipt and expiration

• Experimental protocol documentation:

  • Detailed step-by-step procedures with exact timings

  • Buffer compositions with pH and reagent sources

  • Sample preparation methods

  • Equipment settings and parameters

• Control experiments:

  • Document all positive and negative controls

  • Include validation data demonstrating antibody specificity

  • Record batch effects or variations between experiments

• Data analysis pipeline:

  • Software versions and parameters

  • Statistical methods and thresholds

  • Raw data preservation strategy

This systematic documentation approach enables troubleshooting, protocol optimization, and reproduction of results by other researchers .

How should researchers validate a new lot of SPCC2H8.04 Antibody?

When receiving a new antibody lot, perform these validation steps:

• Side-by-side comparison:

  • Run parallel experiments with previous and new lot

  • Compare signal intensity, specificity, and background

  • Document any differences in optimal dilution or performance

• Establish performance metrics:

  • Signal-to-noise ratio under standardized conditions

  • Detection limit with known concentrations of target

  • Reproducibility across technical replicates

• Specificity confirmation:

  • Test with known positive and negative samples

  • Perform peptide competition assay if discrepancies appear

  • Verify band pattern in Western blot applications

• Stability assessment:

  • Test antibody performance after different storage durations

  • Compare freshly thawed versus previously thawed aliquots

These validation steps ensure experimental continuity across antibody lots and prevent misinterpretation due to lot-specific variations .

How might SPCC2H8.04 Antibody be adapted for high-throughput screening applications?

For high-throughput applications, consider these methodological adaptations:

• Automated Western blot systems:

  • Capillary-based protein separation systems

  • Microfluidic Western blotting platforms

  • Automated sample handling and processing

• High-content screening:

  • Adapt for 96/384-well plate immunofluorescence

  • Optimize fixation and staining for automated imaging

  • Develop computational image analysis pipelines

• Protein array applications:

  • Use as detection reagent for reverse-phase protein arrays

  • Develop dot blot protocols for rapid screening

  • Multiplex with other antibodies using different detection methods

• Flow cytometry adaptation:

  • Develop intracellular staining protocols for yeast cells

  • Optimize fixation/permeabilization for target accessibility

  • Establish appropriate gating strategies

These adaptations require systematic optimization but can significantly increase experimental throughput and statistical power .

What are the considerations for using SPCC2H8.04 Antibody in comparative studies across yeast species?

When extending research to other yeast species, consider:

• Epitope conservation analysis:

  • Perform sequence alignment of SPCC2H8.04 with potential homologs

  • Identify conservation of the specific epitope recognized by the antibody

  • Predict cross-reactivity based on epitope similarity

• Experimental validation strategies:

  • Test antibody on recombinant proteins from different species

  • Include species-specific positive and negative controls

  • Validate with genetic knockouts when available

• Optimization for different yeast species:

  • Adjust cell wall disruption protocols for different cell types

  • Modify buffer conditions for optimal antibody performance

  • Recalibrate antibody concentrations for each species

• Data interpretation frameworks:

  • Account for differences in protein abundance across species

  • Consider evolutionary context when interpreting results

  • Normalize appropriately when making quantitative comparisons

Cross-species studies require thorough validation to ensure that observed differences reflect biological reality rather than technical artifacts .

How can SPCC2H8.04 Antibody contribute to understanding protein function through systems biology approaches?

SPCC2H8.04 Antibody can be integrated into systems biology research through:

• Interactome mapping:

  • Use antibody for co-immunoprecipitation followed by mass spectrometry

  • Validate interactions through reciprocal pull-downs

  • Map interaction networks under different conditions

• Spatio-temporal dynamics:

  • Track protein localization changes during cell cycle or stress

  • Quantify protein abundance changes across conditions

  • Correlate with transcriptomic data for mechanistic insights

• Pathway analysis integration:

  • Position SPCC2H8.04 within known signaling networks

  • Identify functional modules through clustering analysis

  • Predict pathway impacts through mathematical modeling

• Multi-scale data integration:

  • Connect molecular interactions to cellular phenotypes

  • Integrate proteomics, genomics, and metabolomics data

  • Develop predictive models of system behavior

These approaches provide a holistic understanding of protein function within the cellular context, moving beyond isolated observations toward comprehensive biological understanding .

What are the detailed specifications for applications of SPCC2H8.04 Antibody?

This detailed specification helps researchers select appropriate experimental conditions and anticipate compatibility with various detection systems .

How does SPCC2H8.04 Antibody validation compare with best practices in antibody characterization?

Current best practices in antibody validation emphasize multiple validation strategies:

• Genetic validation: Testing antibody in knockout/knockdown models

  • SPCC2H8.04 Antibody should be tested in SPCC2H8.04 deletion strains

  • This represents the gold standard for specificity validation

• Independent antibody validation: Using multiple antibodies targeting different epitopes

  • Currently limited for SPCC2H8.04 due to availability of alternative antibodies

  • Consider developing additional antibodies if critical for research

• Orthogonal validation: Correlating antibody results with orthogonal methods

  • Compare protein detection with mRNA expression levels

  • Use tagged versions of the protein as complementary approach

• Expression validation: Testing across samples with varying expression levels

  • Use inducible expression systems to create gradient of target abundance

  • Verify signal correlation with expected expression changes

• Technical validation: Optimizing experimental conditions

  • Includes titration experiments and blocking studies

  • Essential for establishing robust protocols